Table 5.
Projected direct costs by vaccination strategy for children <10 years old
| Costs with PCV-7 vaccination, US$ |
Cost savings, US$* |
|||
|---|---|---|---|---|
| PHiD-CV vs PCV-7 | PCV-13 vs PCV-7 | PHiD-CV vs PCV-13 | ||
| Vaccine and vaccine administration cost |
156,455,040 |
0 |
0 |
0 |
| IPD cost |
1,217,684 |
−112,966 |
−137,691 |
24,726 |
| Pneumonia hospitalizations cost |
3,939,050 |
−104,850 |
−117,264 |
12,413 |
| AOM cost |
98,833,034 |
−12,500,997 |
−3,228,848 |
−8,272,149 |
| Total direct costs | 260,444,808 | −11,718,813 | −3,483,803 | −8,235,010 |
*Negative numbers represent savings in favor of first comparator.
AOM acute otitis media, IPD invasive pneumococcal disease, PCV-7 7-valent pneumococcal conjugate vaccine, PCV-13 13-valent pneumococcal conjugate vaccine, PHiD-CV pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine.